Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation.
暂无分享,去创建一个
Kevin Weiss | Laura E Niklason | Thomas H Barker | F. Martinez | L. Niklason | T. Barker | E. White | J. Horowitz | B. Moore | Eric S White | Fernando J Martinez | Ashley M. Cornett | Adam J Booth | Ryan Hadley | Ashley M Cornett | Alyssa A Dreffs | Stephanie A Matthes | Jessica L Tsui | Jeffrey C Horowitz | Vincent F Fiore | Bethany B Moore | A. Booth | Jessica L. Tsui | R. Hadley | Alyssa A. Dreffs | Stephanie A. Matthes | Vincent F. Fiore | K. Weiss | Adam J. Booth
[1] T. Barker,et al. Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction. , 2012, American journal of respiratory cell and molecular biology.
[2] Steven A. Carr,et al. The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices , 2011, Molecular & Cellular Proteomics.
[3] E. White,et al. Decellularized Human Lung Slices Implicate The Extracellular Matrix In Directing Fibroblast Phenotypes , 2011, ATS 2011.
[4] E. White. Accessory cardiac bronchus. , 2011, American journal of respiratory and critical care medicine.
[5] S. Kato,et al. Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias , 2010, European Respiratory Journal.
[6] A. Kho,et al. Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression , 2010, The Journal of cell biology.
[7] Christian Schuetz,et al. Regeneration and orthotopic transplantation of a bioartificial lung , 2010, Nature Medicine.
[8] Zhen W. Zhuang,et al. Tissue-Engineered Lungs for in Vivo Implantation , 2010, Science.
[9] Angela Panoskaltsis-Mortari,et al. Development of a decellularized lung bioreactor system for bioengineering the lung: the matrix reloaded. , 2010, Tissue engineering. Part A.
[10] Jean A. Niles,et al. Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation. , 2010, Tissue engineering. Part A.
[11] D. Schroeder,et al. Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results. , 2010, American journal of respiratory and critical care medicine.
[12] S. Wood,et al. Connective Tissue Growth Factor Promotes Fibrosis Downstream of TGFβ and IL‐6 in Chronic Cardiac Allograft Rejection , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[13] G. Verleden,et al. Tracheal allotransplantation after withdrawal of immunosuppressive therapy. , 2010, The New England journal of medicine.
[14] P. Thurner. Atomic force microscopy and indentation force measurement of bone. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[15] J. Hagood,et al. Emerging concepts in the pathogenesis of lung fibrosis. , 2009, The American journal of pathology.
[16] Valerie M. Weaver,et al. A tense situation: forcing tumour progression , 2009, Nature Reviews Cancer.
[17] Lewis H Romer,et al. Cell traction forces direct fibronectin matrix assembly. , 2009, Biophysical journal.
[18] T. Wynn,et al. Pulmonary fibrosis: pathogenesis, etiology and regulation , 2009, Mucosal Immunology.
[19] Sara Mantero,et al. Clinical transplantation of a tissue-engineered airway , 2008, The Lancet.
[20] J. Hutson,et al. Lungs, Pleura and Mediastinum , 2008 .
[21] Doris A Taylor,et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart , 2008, Nature Medicine.
[22] C. Hogaboam,et al. Murine models of pulmonary fibrosis. , 2008, American journal of physiology. Lung cellular and molecular physiology.
[23] Michiya Matsusaki,et al. The construction of 3D-engineered tissues composed of cells and extracellular matrices by hydrogel template approach. , 2007, Biomaterials.
[24] M. Medvedovic,et al. Genomic Profile of Matrix and Vasculature Remodeling in TGF-α–Induced Pulmonary Fibrosis , 2007 .
[25] David S. Rogers,et al. Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts. , 2007, Cellular signalling.
[26] R L Ehman,et al. Magnetic resonance elastography of the lung: Technical feasibility , 2006, Magnetic resonance in medicine.
[27] F Verrecchia,et al. [Cellular and molecular mechanisms of fibrosis]. , 2006, Annales de pathologie.
[28] R. Neubert,et al. Characterization of peptides resulting from digestion of human skin elastin with elastase , 2005, Proteins.
[29] Takeshi Imamura,et al. The ALK‐5 inhibitor A‐83‐01 inhibits Smad signaling and epithelial‐to‐mesenchymal transition by transforming growth factor‐β , 2005, Cancer science.
[30] R. Lévy,et al. Specific molecular interactions by force spectroscopy: from single bonds to collective properties. , 2005, Biophysical chemistry.
[31] A. Nicholson,et al. Induction of Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells by Transforming Growth Factor-β1 : Potential Role in Idiopathic Pulmonary Fibrosis , 2005 .
[32] C. Daniels,et al. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. , 2004, The Journal of clinical investigation.
[33] D. Hanahan,et al. Direct Test of Potential Roles of EIIIA and EIIIB Alternatively Spliced Segments of Fibronectin in Physiological and Tumor Angiogenesis , 2004, Molecular and Cellular Biology.
[34] D. Livant,et al. Integrin alpha4beta1 regulates migration across basement membranes by lung fibroblasts: a role for phosphatase and tensin homologue deleted on chromosome 10. , 2003, American journal of respiratory and critical care medicine.
[35] Melinda Larsen,et al. Fibronectin requirement in branching morphogenesis , 2003, Nature.
[36] D. Bissell. Chronic liver injury, TGF-β, and cancer , 2001, Experimental & Molecular Medicine.
[37] Kenneth M. Yamada,et al. Taking Cell-Matrix Adhesions to the Third Dimension , 2001, Science.
[38] H. Dietz,et al. Mouse models of genetic diseases resulting from mutations in elastic fiber proteins. , 2000, Matrix biology : journal of the International Society for Matrix Biology.
[39] N. Kaminski,et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. , 1999, Cell.
[40] A. Geinoz,et al. The Fibronectin Domain ED-A Is Crucial for Myofibroblastic Phenotype Induction by Transforming Growth Factor-β1 , 1998, The Journal of cell biology.
[41] Dean Y. Li,et al. Elastin is an essential determinant of arterial morphogenesis , 1998, Nature.
[42] K. Csaky,et al. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. , 1997, The Journal of clinical investigation.
[43] D. Meehan,et al. Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome. , 1996, Genes & development.
[44] A. Skubitz,et al. Two separate domains of laminin promote lung organogenesis by different mechanisms of action. , 1995, Developmental biology.
[45] R. Hynes,et al. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. , 1993, Development.
[46] J. McDonald,et al. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. , 1991, The American journal of pathology.
[47] J. Cassiman,et al. Membrane-associated chondroitin sulfate proteoglycans of human lung fibroblasts , 1989, The Journal of cell biology.
[48] M. L. R. D. Christenson,et al. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management , 2012 .
[49] M. Medvedovic,et al. Genomic profile of matrix and vasculature remodeling in TGF-alpha induced pulmonary fibrosis. , 2007, American journal of respiratory cell and molecular biology.
[50] F. Martinez,et al. Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10). , 2006, American journal of respiratory and critical care medicine.
[51] G. Galea,et al. Processing of Whole Femoral Head Allografts: Validation Methodology for the Reliable Removal of Nucleated Cells, Lipid and Soluble Proteins Using a Multi-step Washing Procedure , 2005, Cell and Tissue Banking.
[52] A. Nicholson,et al. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. , 2005, The American journal of pathology.
[53] D. Bissell. Chronic liver injury, TGF-beta, and cancer. , 2001, Experimental & molecular medicine.
[54] G. Laurent,et al. Mechanisms of tissue repair: from wound healing to fibrosis. , 1997, The international journal of biochemistry & cell biology.
[55] J. Butler,et al. Poissons' ratio of lung parenchyma and parenchymal interaction with bronchi. , 1986, The Japanese journal of physiology.